Medinotec (MDNC) Cash & Equivalents (2022 - 2026)

Medinotec (MDNC) has 4 years of Cash & Equivalents data on file, last reported at $2.9 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 6.74% year-over-year to $2.9 million; the trailing twelve-month figure through Nov 2025 stood at $2.9 million (up 6.74% YoY), and the FY2025 full-year result was $2.8 million, down 1.4% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $2.9 million, up from $2.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $3.6 million in Q2 2022 and bottomed at $131577.0 in Q1 2022.
• The 4-year median for Cash & Equivalents is $2.8 million (2024), against an average of $2.6 million.
• Peak annual rise in Cash & Equivalents reached 2048.9% in 2023, while the deepest fall reached 23.93% in 2023.
• A 4-year view of Cash & Equivalents shows it stood at $2.8 million in 2022, then dropped by 5.9% to $2.7 million in 2023, then retreated by 0.08% to $2.7 million in 2024, then grew by 6.74% to $2.9 million in 2025.
• The last three Cash & Equivalents figures came in at $2.9 million (Q4 2025), $2.2 million (Q3 2025), and $2.0 million (Q2 2025), per Business Quant data.

Peer Comparison